Literature DB >> 27067319

Impact of Cefepime Susceptible-Dose-Dependent MIC for Enterobacteriaceae on Reporting and Prescribing.

Christina G Rivera1, Prasanna P Narayanan2, Robin Patel3, Lynn L Estes4.   

Abstract

The CLSI cefepime breakpoints were revised to include a susceptible-dose-dependent (SDD) category for Enterobacteriaceae, with the intention that higher cefepime doses be used for these isolates. In this study, 1.6% of Enterobacteriaceae isolates were reported as SDD, with Escherichia coli the most common SDD organism. Cefepime was prescribed in three cases (4.8%); the majority of SDD isolates were treated with a carbapenem. Enterobacteriaceae with cefepime SDD MICs were not commonly treated with cefepime at our institution.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27067319      PMCID： PMC4879407          DOI： 10.1128/AAC.00442-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Secular trends associated with Enterobacteriaceae with a cefepime susceptible-dose-dependent MIC.

Authors:  Jamie L Wagner; Rachel M Kenney; Robert J Tibbetts; Susan L Davis
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

2.  Impact of revised cefepime CLSI breakpoints on Escherichia coli and Klebsiella pneumoniae susceptibility and potential impact if applied to Pseudomonas aeruginosa.

Authors:  Yukihiro Hamada; Christina A Sutherland; David P Nicolau
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

Review 3.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

4.  Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.

Authors:  Marcelle D Alves; Vanessa B Ribeiro; Jardel P Tessari; Francine Mattiello; Giordanna De Bacco; Daniela I Luz; Fabiane J Vieira; Tainá F Behle; Alessandro C Pasqualotto; Alexandre P Zavascki
Journal:  J Antimicrob Chemother       Date:  2014-01-27       Impact factor: 5.790
  4 in total
  2 in total

1.  Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study.

Authors:  Jennifer L Adema; Laurel N Lake; Ryan W Stevens; Breann M Hogan; Audrey N Schuetz; Aaron J Tande; Kristin C Mara; Allison R Eberly; Christina G Rivera
Journal:  Open Forum Infect Dis       Date:  2022-01-10       Impact factor: 3.835

2.  Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia.

Authors:  Kap Sum Foong; Abigail L Carlson; Satish Munigala; Carey-Ann D Burnham; David K Warren
Journal:  Open Forum Infect Dis       Date:  2019-07-28       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.